Menu
1998 Special Session I

Budget Bill - HB4001 (Introduced)

Department of Health

Item 321

Item 321

First Year - FY1999Second Year - FY2000
Communicable and Chronic Disease Prevention and Control (40500)$39,522,330$40,177,414
Cancer Prevention and Control (40501)FY1999 $188,663FY2000 $191,377
Immunization Services (40502)FY1999 $6,506,577FY2000 $6,652,477
Tuberculosis Prevention and Control (40503)FY1999 $1,632,597FY2000 $1,636,194
Venereal Disease Prevention and Control (40504)FY1999 $1,792,524FY2000 $1,814,865
Epidemiological Services (40505)FY1999 $1,788,054FY2000 $1,360,421
Acquired Immune Deficiency Prevention and Treatment Services (40506)FY1999 $17,487,309FY2000 $18,368,786
Technical Assistance and Support for Prevention and Control of Communicable and Chronic Diseases (40507)FY1999 $4,967,101FY2000 $4,986,932
Financial Assistance for Health Prevention and Promotion (40508)FY1999 $5,159,505FY2000 $5,166,362
Fund Sources: 
GeneralFY1999 $10,314,712FY2000 $9,902,970
SpecialFY1999 $278,756FY2000 $278,756
Federal TrustFY1999 $28,928,862FY2000 $29,995,688

Authority: §§ 32.1-11.1 through 32.1-11.2; 32.1-55.1; 32.1-35 through 32.1-73, Code of Virginia; and P.L. 91-464, as amended, Federal Code.


A. Out of this appropriation, $1,325,000 the first year and $1,325,000 the second year is provided from the general fund to support the regional AIDS resource and consultation centers and one local early intervention and treatment center.


B. Out of this appropriation, $150,000 the first year and $150,000 the second year is provided from the general fund to support the Arthur Ashe Health Center in Richmond.


C. Appropriations from this item included for sexual assault centers may be used for adult and children's services provided by the centers.


D. Any funds provided in this item for the Virginia HIV Medications Assistance Program which are unexpended on June 30, 1999, shall not revert to the general fund but shall be reappropriated for the same use in the succeeding year.


E. Out of this appropriation, $50,000 the first year and $50,000 the second year from the general fund shall be provided to the Richmond AIDS Ministry.


F. The General Assembly finds that access to pharmaceutical therapies is important for treating HIV patients and that patients should have access to a wide range of treatment options as determined under consultation with a physician. The Department shall examine clinical evidence and national guidelines quarterly in order to determine whether additional appropriate forms of treatment and funding for these treatments should be made available through the Virginia HIV Medications Assistance Program. The Department shall report by December 1 of each year to the Joint Subcommittee Studying HIV on its findings and recommendations resulting from an examination of new therapies, including what, if any, additional treatment options and funding should be made available through the Virginia HIV Medications Assistance Program.